From September 4-7, 2022, the 18th International Myopia Conference will be held in Rotterdam, the Netherlands. This is the largest international myopia convention, bringing together vision and basic scientists, clinical experts, as well as policy makers. It will incorporate research from bench to bedside and will answer all your questions on myopia control and new interventions. The conference will cover all aspects of research in the field of myopia. This year’s conference will be more clinically oriented than previous editions.
Abstract submission and registration are now open! The Local Organizing Committee is pleased to announce that it has revisited the timeline for abstract submissions for the 2022 International Myopia Conference. The new deadline for submission of abstracts is now 23:59 PM, May 31st 2022
This allows not only for more time but also for the abstracts on more current research.
Please click here to visit the IMC 2022 conference website to submit your abstract, register and view the program at a glance. We hope to see you all in Rotterdam!
Postponed for 2021 due to COVID-19 restrictions for travelling and gathering, the 18th International Myopia Conference now has a new date and location for 2022.
The 18th International Myopia Conference will take place in Rotterdam, The Netherlands, from September 4th to 7th 2022. The 18th IMC will be hosted by the Erasmus Medical Center at the De Doelen, chaired by International Myopia Institute Committee Leader (Myopia Genetics) and Member, Professor Caroline Klaver.
“The 2022 International Myopia Conference will focus on fostering collaborations, connections and political actions required to place myopia at the top of the global health agenda, with the ultimate aim to prevent blindness from myopia in the generations to come,” said Professor Klaver.
“We look forward to creating a unique forum for knowledge exchange, and will make a strong effort to connect vision and basic scientists to clinical experts and policy makers. Myopia’s broad spectrum of causes and consequences necessitate a comprehensive panel of experts to elucidate mechanisms, define targets for therapy, and help solve current clinical dilemma’s.”